Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupSANZ, Miguel A; MARTIN, Guillermo; DE LA SERNA, Javier et al.Blood. 2004, Vol 103, Num 4, pp 1237-1243, issn 0006-4971, 7 p.Article

Influence of Pre-and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma : Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer SurvivalLAHUERTA, Juan José; MATEOS, Maria Victoria; BESALDUCH, Joan et al.Journal of clinical oncology. 2008, Vol 26, Num 35, pp 5775-5782, issn 0732-183X, 8 p.Article

High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphomaSALAR, Antonio; MARTINO, Rodrigo; PEREA, Granada et al.Haematologica (Roma). 2002, Vol 87, Num 10, pp 1028-1035, issn 0390-6078Article

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimensMONTESINOS, Pau; RAYON, Chelo; RIVAS, Concha et al.Blood. 2011, Vol 117, Num 6, pp 1799-1805, issn 0006-4971, 7 p.Article

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic LeukemiaBOSCH, Francesc; ABRISQUETA, Pau; GARCIA MARCO, José Antonio et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4578-4584, issn 0732-183X, 7 p.Article

High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphomaMONTOTO, Silvia; MORENO, Carol; ASENSIO, Antoni et al.Haematologica (Roma). 2008, Vol 93, Num 2, pp 207-214, issn 0390-6078, 8 p.Article

High-Dose Chemotherapy and Immunotherapy in Adult Burkitt Lymphoma : Comparison of Results in Human Immunodeficiency Virus-Infected and Noninfected PatientsORIOL, Albert; RIBERA, Josep-Maria; HOELZER, Dieter et al.Cancer. 2008, Vol 113, Num 1, pp 117-125, issn 0008-543X, 9 p.Article

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapyGUTIERREZ-GARCIA, Gonzalo; CARDESA-SALZMANN, Teresa; MARTINEZ, Salomé et al.Blood. 2011, Vol 117, Num 18, pp 4836-4843, issn 0006-4971, 8 p.Article

Busulfan 12 mg/kg plus melphalan 140 mg/m² versus melphalan 200 mg/m² as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 studyLAHUERTA, Juan José; MATEOS, Maria Victoria; CARRERA, Dolores et al.Haematologica (Roma). 2010, Vol 95, Num 11, pp 1913-1920, issn 0390-6078, 8 p.Article

Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia : High Response Rate and Disease EradicationBOSCH, Francesc; FERRER, Ana; ASENSI, Antoni et al.Clinical cancer research. 2008, Vol 14, Num 1, pp 155-161, issn 1078-0432, 7 p.Article